Effects of Adding Basal Insulin on Endothelial Progenitor Cell Levels in Poorly-Controlled Type 2 Diabetic Patients With Cardiovascular Disease. A Randomized Cross-Over Study Comparing Insulin Detemir and Glargine
Phase of Trial: Phase IV
Latest Information Update: 27 Feb 2015
At a glance
- Drugs Insulin detemir (Primary) ; Insulin glargine (Primary)
- Indications Type 2 diabetes mellitus
- Focus Pharmacodynamics
- Acronyms LIBRA
- 31 Aug 2018 Biomarkers information updated
- 01 Aug 2011 Results published in Diabetes, Obesity and Metabolism.
- 30 Mar 2010 Status changed from recruiting to completed as reported by ClinicalTrials.gov.